PTLD treatment: A step forward, a long way to go

The Lancet Oncology

Volumn 13, Issue 2, 2012, Pages 120-121

  Montserrat, Emili ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

B CELL LYMPHOMA; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EPSTEIN BARR VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOPROLIFERATIVE DISEASE; ORGAN TRANSPLANTATION; POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T CELL LYMPHOMA; TREATMENT RESPONSE; VIRUS LOAD;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; ORGAN TRANSPLANTATION; PREDNISOLONE; VINCRISTINE;

EID: 84856491772     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70325-4     Document Type: Letter

References (6)

1. Swerdlow SH, Webber SA, Chadburn A, Ferry JA Post-transplant lymphoproliferative disorders. Classification of tumours of haematopoietic and lymphoid tissues 2008, 243-250. IARC, Lyon. 4th edn. S.H. Sherdlow, E. Campo, N. Harris (Eds.).
2. Parker A, Bowles K, Bradley JA, et al. Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients. BCSH and BTS Guidelines. Br J Haematol 2010, 149:693-705.
3. Heslop HE How I treat EBV lymphoproliferation. Blood 2009, 114:4002-4008.
4. Evens AM, David KA, Helenowski I, et al. Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era. J Clin Oncol 2010, 28:1038-1046.
5. Haque T, Wilkie GM, Jones MM, et al. Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood 2007, 110:1123-1131.
6. Trappe R, Oertel S, Leblond V, et al. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol 2011, for the German PTLD Study Group and the European PTLD Network, published online Dec 13. 10.1016/S1470-2045(11)70300-X.